Rose Schwarz and her family will travel to Mexico next week to try some new treatments that will hopefully cure the Lyme disease that plagues the 74-pound woman. A successful online fundraiser for Schwarz brought in more than $23,000 last month, which opened up new options for treatment. Once the funds came in, Roses mom Tani Schwarz spent days researching online and talking to multiple doctors and patients before making the decision to head to Mexico for three weeks of alternative, complementary and integrative therapy at Baja MedGate in Baja Mexico. Treatment down there is way more state-of-the-art and modern than here, contrary to popular belief, Tani said. She and Rose will travel to Baja MedGate on June 6, when the therapy will start. The first two days will involve extensive specific testing and blood analysis, Tani said. Treatment will include IV delivery of specific detox, nutrition and immune support, essential fatty acid therapy, cocarboxilasa protocol, symphatic therapy, magnetic and ozone therapy, GcMAF therapy, high dose IV curcumin therapy and Mesenchymal stem cell therapy taken from donated adipose tissue. Rose will also receive bioidentical hormone replacement testing and treatment to help with her extremely low bone mass. While some of … Continue reading →

Nearly 1,650 people in the U.S. are awaiting lung transplants. Unfortunately, both domestically and abroad, the demand for donor lungs far outpaces the supply. The limited availability of donor lungs can lead to long delays before transplant, leaving patients to face a mortality rate of up to 40 percent while they wait. Most potentially transplantable lungs are rejected by surgical teams because of injury or dysfunction, such as pulmonary edema (fluid build-up in the lungs). In addition to rendering lungs unusable for transplant, pulmonary edema also signals that the lungs are not functioning properly post-transplant and is a major cause of illness and death among lung transplant recipients. Lungs that can clear fluid better are associated with better outcomes among recipients after transplantation. In this study, Danny F. McAuley, Gerard F. Curley, Umar I. Hamid, John G. Laffey, Jason Abbott, David H. McKenna, Xiaohui Fang, Michael A. Matthay, and Jae W. Lee looked at whether lungs that were rejected for transplantation because of edema could be "reconditioned" to qualify for transplant. They studied donor lungs that had been rejected for transplantation by the Northern California Transplant Donor Network and that were cleared for research use by the donors' families. Roughly … Continue reading →